The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBOTT LABS | COM | 002824100 | 44,410 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 42,413 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 104,109 | 435,750 | SH | SOLE | 435,750 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047102 | 6,205 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 2,569 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
BIOLASE INC | WARRANTS | 090911108 | 0 | 1,841,173 | SH | Call | SOLE | 1,841,173 | 0 | 0 | |
BIOLASE INC | COM | 090911108 | 7,199 | 5,332,394 | SH | SOLE | 5,332,394 | 0 | 0 | ||
BIOSCRIP INC | COM | 09069N108 | 17,306 | 10,180,000 | SH | SOLE | 10,180,000 | 0 | 0 | ||
BIOVERATIV INC | COM | 09075E100 | 59,906 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
BROOKDALE SENIOR LIVING | COM | 112463104 | 73,865 | 5,500,000 | SH | SOLE | 5,500,000 | 0 | 0 | ||
CARDIOVASCULAR SYSTEMS INC | COM | 141619106 | 49,481 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
TARGACEPT INC | NOTE | 87611RAA6 | 1,685 | 1,684,799 | PRN | SOLE | 1,684,799 | 0 | 0 | ||
DEXTERA SURGICAL INC. | COM | 252366109 | 888 | 837,483 | SH | SOLE | 837,483 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 56,380 | 5,052,000 | SH | SOLE | 5,052,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 43,440 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
GENOMIC HEALTH INC | COM | 37244C101 | 77,406 | 2,458,100 | SH | SOLE | 2,458,100 | 0 | 0 | ||
GILEAD SCIENCES, INC. | COM | 375558103 | 67,920 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
GILEAD SCIENCES, INC. | COM | 375558103 | 129,048 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 26,523 | 2,398,123 | SH | SOLE | 2,398,123 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 58,812 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
MYLAN NV | SHS EURO | N59465109 | 161,648 | 4,145,889 | SH | SOLE | 4,145,889 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 83,040 | 4,325,000 | SH | SOLE | 4,325,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 126,738 | 5,400,000 | SH | SOLE | 5,400,000 | 0 | 0 | ||
ORTHOFIX INTL N V | COM | N6748L102 | 57,225 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
PERRIGO CO PLC | SHS | G97822103 | 53,656 | 808,200 | SH | SOLE | 808,200 | 0 | 0 | ||
PTC THERAPEUTICS | COM | 69366J200 | 12,300 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 24,180 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 39,960 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
SELECT MEDICAL HOLDINGS CORP | COM | 81619Q105 | 66,750 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
SPDR S&P 500 ETF Trust | COM | 78462F103 | 235,740 | 1,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | |
SPDR S&P 500 ETF Trust | COM | 78462F103 | 471,480 | 2,000,000 | SH | Put | SOLE | 2,000,000 | 0 | 0 | |
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 24,767 | 2,347,593 | SH | SOLE | 2,347,593 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) | ADR | 881624209 | 167,396 | 5,216,450 | SH | SOLE | 5,216,450 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 71,078 | 650,000 | SH | SOLE | 650,000 | 0 | 0 |